Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...
DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...
This morning medical device company Medtronic announced its plans to buy Companion Medical, which is best known for making the InPen, an insulin pen that integrates a companion app, for an undisclosed ...
Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...
Shortly after acquiring smart insulin-pen-maker Companion Medical, Medtronic has officially launched the InPen device alongside integration with its Guardian Connect connected glucose monitoring (CGM) ...
Mike Mensinger, vice president of engineering at Medtronic Diabetes, talks about how the company’s products and services help people manage diabetes to improve their lives. Medtronic is a medical ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) and Companion Medical, Inc. today announced a collaboration to enable a direct exchange of CGM data from Dexcom with insulin data from InPen™ ...
Medtronic is buying up leading smart insulin pen and connected phone app maker Companion Medical as it looks to shore up its growing weakness in the pump market. The med tech major gets access to ...
Medtronic plc has reported the launch of the Inpen integrated with real-time Guardian Connect continuous glucose monitoring (CGM) data. Inpen is the first U.S. FDA-cleared smart insulin pen on the ...
Medtronic Diabetes has been hit with a class action lawsuit. The lawsuit, filed in August 30, 2023 in a California federal court, alleges that Medtronic engaged in “transmission and disclosure” of ...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results